Skip to main content
Immunology logoLink to Immunology
. 1981 Apr;42(4):505–511.

Quantitative differences between complement factor-B phenotypes.

J P Mortensen, L U Lamm
PMCID: PMC1458261  PMID: 7016742

Abstract

In a study of 365 unrelated blood donors the structural polymorphism was determined by high-voltage electrophoresis followed by immunofixation with monospecific anti-Bf serum as described by Alper, Boenish & Watson (1972), and serum levels were measured by rocket-immunoelectrophoresis as described by Sjöholm (1975). We found that the mean level of Factor B in relation to structural phenotypes varies significantly in the order BfF greater than BfFS greater than BfS, though great variation was observed within types. A similar difference was also found with a functional assay of Factor B in agarose plates, although this method is less accurate. Concerning the biological functions, such as opsonization and bacteriolysis, it might be that individuals with the BfF allele are more able to withstand infectious agents than BfS subjects. The Bf polymorphism may therefore be transient, the BfF allele being in a process of replacing BfS by natural selection.

Full text

PDF
505

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Boenisch T., Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med. 1972 Jan;135(1):68–80. doi: 10.1084/jem.135.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bender K., Mayerová A., Frank R., Hiller C., Wienker T. Haplotype analysis of the linkage group HLA-A:HAL-B:Bf and its bearing on the interpretation of the linkage disequilibrium. Hum Genet. 1977 Apr 15;36(2):191–196. doi: 10.1007/BF00273257. [DOI] [PubMed] [Google Scholar]
  3. Brönnestam R. Studies on the C3 polymorphism. Relationship between phenotype and quantitative immunochemical measurements. Hum Hered. 1973;23(2):128–134. doi: 10.1159/000152564. [DOI] [PubMed] [Google Scholar]
  4. Fu S. M., Kunkel H. G., Brusman H. P., Allen F. H., Jr, Fotino M. Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med. 1974 Oct 1;140(4):1108–1111. doi: 10.1084/jem.140.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HOPKINSON D. A., SPENCER N., HARRIS H. GENETICAL STUDIES ON HUMAN RED CELL ACID PHOSPHATASE. Am J Hum Genet. 1964 Mar;16:141–154. [PMC free article] [PubMed] [Google Scholar]
  6. Olaisen B., Teisberg P., Gedde-Dahl T., Thorsby E. The Bf locus in the HLA region of chromosome 6: linkage and association studies. Humangenetik. 1975 Dec 23;30(4):291–296. doi: 10.1007/BF00275141. [DOI] [PubMed] [Google Scholar]
  7. Raum D., Alper C. A., Stein R., Gabbay K. H. Genetic marker for insulin-dependent diabetes mellitus. Lancet. 1979 Jun 9;1(8128):1208–1210. doi: 10.1016/s0140-6736(79)91895-6. [DOI] [PubMed] [Google Scholar]
  8. Sjöholm A. G. Complement components in normal serum and plasma quantitated by electroimmunoassay. Scand J Immunol. 1975;4(1):25–30. doi: 10.1111/j.1365-3083.1975.tb02596.x. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES